Mr. Andre Jerome reports

AURORA EXPANDS MEDICAL CANNABIS OFFERINGS IN AUSTRALIA WITH THE LAUNCH OF INDIMED TEMPO 22

Aurora Cannabis Inc. has expanded its popular IndiMed brand with the launch of IndiMed Tempo 22, available through the company's subsidiary, MedReleaf Australia. With the same consistent quality and reliable supply, this new 22-per-cent tetrahydrocannabinol potency creates a greater range of treatment options available to prescribers.

"Expanding our portfolio in the value segment in Australia reinforces our commitment to meet increasingly diversified patient needs with accessible, high-quality medical cannabis options," said Andre Jerome, executive vice-president of global business development at Aurora. "As a global leader in medical cannabis, we're proud to offer a diverse range of products that reflect both local demand and our dedication to innovation worldwide."

IndiMed remains one of the most prescribed medical cannabis brands for patients in Australia. The two new cultivars available include:

• IndiMed Tempo 22, lemon laser -- sativa, 22 per cent THC, less than 1 per cent cannabidiol, dried cannabis (15 grams);
• IndiMed Tempo 22, pickled petrol -- indica, 22 per cent THC, less than 1 per cent CBD, dried cannabis (15 grams).

Aurora's continued focus on international growth and deep commitment to providing patients with innovative products and expanded access enable the company to maintain its global leadership position.

MedReleaf Australia, a wholly owned subsidiary of Aurora, is committed to quality and proudly meeting all Therapeutic Goods Administration good manufacturing practice standards.

About Aurora Cannabis Inc.

Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and New Zealand. Headquartered in Edmonton, Alta., Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co., as well as international brands Pedanios, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation and with a focus on high-quality cannabis products, Aurora has brands that continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched.

Aurora's common shares trade on Nasdaq and the Toronto Stock Exchange under the symbol ACB.

We seek Safe Harbor.